OptiBiotix Health (LON:OPTI) Hits New 1-Year Low – Should You Sell?

OptiBiotix Health Plc (LON:OPTI) hit a new 52-week low on Monday . The company traded as low as GBX 6.06 and last traded at GBX 6.50, with a volume of 841553 shares. The stock had previously closed at GBX 6.60.

OptiBiotix Health Stock Performance

The stock has a market cap of £6.46 million, a price-to-earnings ratio of -208.33 and a beta of 1.71. The stock’s 50-day simple moving average is GBX 7.34 and its 200-day simple moving average is GBX 9.53.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.